Raymond James Financial Services Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$21.87 - $28.24 $90,235 - $116,518	-4,126 Reduced 34.39%	7,872 $204,000
Q1 2024 Apr 22, 2024	BUY	$27.21 - $39.48 $13,985 - $20,292	514 Added 4.48%	11,998 $343,000
Q4 2023 Jan 16, 2024	SELL	$21.2 - $31.03 $211,342 - $309,338	-9,969 Reduced 46.47%	11,484 $351,000
Q3 2023 Oct 24, 2023	SELL	$26.2 - $36.08 $15,143 - $20,854	-578 Reduced 2.62%	21,453 $576,000
Q2 2023 Jul 25, 2023	BUY	$25.16 - $41.38 $138,631 - $228,003	5,510 Added 33.35%	22,031 $785,000
Q1 2023 Apr 14, 2023	SELL	$23.68 - $38.51 $43,713 - $71,089	-1,846 Reduced 10.05%	16,521 $419,000
Q4 2022 Feb 08, 2023	SELL	$28.0 - $40.56 $28,420 - $41,168	-1,015 Reduced 5.24%	18,367 $744,000
Q3 2022 Oct 25, 2022	BUY	$29.63 - $48.31 $14,992 - $24,444	506 Added 2.68%	19,382 $641,000
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $1.29 Million - $2.34 Million	-46,256 Reduced 71.02%	18,876 $665,000
Q1 2022 May 11, 2022	BUY	$39.62 - $69.97 $1.18 Million - $2.09 Million	29,863 Added 84.67%	65,132 $3 Million
Q4 2021 Feb 08, 2022	BUY	$58.09 - $82.51 $179,091 - $254,378	3,083 Added 9.58%	35,269 $2.34 Million
Q3 2021 Nov 02, 2021	BUY	$58.38 - $84.96 $488,815 - $711,370	8,373 Added 35.16%	32,186 $2.01 Million
Q2 2021 Aug 11, 2021	BUY	$62.15 - $90.32 $279,737 - $406,530	4,501 Added 23.31%	23,813 $1.97 Million
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $78,221 - $115,349	-1,275 Reduced 6.19%	19,312 $1.28 Million
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $413,660 - $805,892	-9,440 Reduced 31.44%	20,587 $1.58 Million
Q3 2020 Nov 04, 2020	SELL	$33.21 - $51.27 $143,068 - $220,871	-4,308 Reduced 12.55%	30,027 $1.29 Million
Q2 2020 Jul 17, 2020	SELL	$26.12 - $43.27 $72,326 - $119,814	-2,769 Reduced 7.46%	34,335 $1.48 Million
Q1 2020 Apr 21, 2020	SELL	$20.56 - $63.12 $61,741 - $189,549	-3,003 Reduced 7.49%	37,104 $1.07 Million
Q4 2019 Feb 12, 2020	BUY	$28.14 - $73.01 $304,165 - $789,165	10,809 Added 36.89%	40,107 $2.54 Million
Q3 2019 Nov 07, 2019	BUY	$26.26 - $34.86 $769,365 - $1.02 Million	29,298 New	29,298 $826,000
Q2 2018 Jul 30, 2018	SELL	$6.37 - $14.02 $73,458 - $161,678	-11,532 Closed	0 $0
Q1 2018 Apr 16, 2018	BUY	$3.72 - $7.64 $42,899 - $88,104	11,532 New	11,532 $83,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account